GREEN BIOTECH HELLAS ΔΗΜΗΤΡΗΣ ΠΑΝΑΓΟΠΟΥΛΟΣ - Metsovou 27

μπραβο

Καινοτομία και επιστήμη, μπράβο!

Εξειδικευμενος χώρος, πολύ καλά καταρτισμένοι οι συνεργάτες, ευρύ πεδίο δράσης

Εξαιρετική συνεργασία με τη Novartis central lab και την Ιατρική σχολή του Πανεπιστημίου Αθηνών στις μελέτες βιοδεικτών του χρόνιου στρες σε σχέση με τα καρδιαγγειακά νοσήματα.

Τα θερμά μου συγχαρητήρια για το επίπεδο του εργαστηρίου της Ελλάδας και της Γερμανίας που εμπιστεύθηκα πρόσφατα με αφορμή την αξιολόγηση και διαπίστευση από το International Research Cloud for Biochemistry & Biotechnology - IRCBB. Συνεχίστε την εξαιρετική δουλειά! IRCBB is an association of approved and certified biotechnology companies offering a wide range of innovative services. The entirety of the methods and protocols used follow international scientific standards in accordance with EN ISO/IEC 17025, 15189, 13485, 14001, 37001, are accepted and approved as scientifically valid and effective by EAA, NCBI, EMBO, AASA, AAS, WHO, FDA, EMA, WTO, and IDO. Official members of IRCBB are checked monthly through interlaboratory tests and scenarios.

Congrats!!!!!!!!!!!!!!!!!!!!!!

International Research Cloud for Biochemistry & Biotechnology (IRCBB) is an association of 34 approved and certified laboratories in 24 countries offering a wide range of innovative services in the sectors of the industry, commerce, health, and the environment. The entirety of the methods and protocols used follow international scientific standards in accordance with EN ISO/IEC 17025, 15189, 13485, 14001, 37001, are accepted and approved as scientifically valid and research-effective by EAA, NCBI, EMBO, AASA, AAS, WHO, FDA, EMA, WTO, and IDO. Official members of IRCBB are checked monthly through interlaboratory tests and scenarios. IRCBB declare that GREEN BIOTECH HELLAS, as an official member, in the context of the collaboration with other goverment or not agencies and/or non for profit organisations in the Control of Drug and Alcohol, meets and will maintain compliance with the following criteria: 1.Two independent analytic methods are used for determining a positive result: – A screening process, usually an immunoassay screen, on one portion of the original specimen – A confirmatory test, usually gas or liquid chromatography, in combination with mass spectrometry on a different portion of the original specimen. 2.Specimen validity testing is performed that is appropriate to the specific specimen tested, including reliably identifying specimens that are adulterated or substituted. 3.The testing methodology reliably discriminates between specimens that contain drug(s) at or above the in the context of the cooperation with the sector. 4.Chain of Custody (COC) procedures (including both specimens and aliquots) are used throughout the laboratory. 5.Quality control procedures include: – Internal open and blind controls – Enrolment in an external blind and blind quality assurance/proficiency testing program for drug testing services offered. 6.Personnel qualifications are documented, and competency assessments are performed annually. 7.Laboratory safety procedures are implemented to protect the health and safety of employees and visitors. 8.Quality improvement and quality management are an integral part of laboratory operations. 9.Document-control procedures are implemented. 10.Records and specimen management procedures are implemented. 11.Method validation and verification is performed, and records maintained. 12.Internal and external facility and on-site inspections/audits occur at least once every two years and records are available for review. 13.Security of specimens, records, and the testing area/facility is maintained.